This inventor holds 2 USPTO granted patents, plus 3 CIPO patents. Top assignees: Antlera Therapeutics Inc., Modmab Therapeutics Corporation. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Xiaowei Wang: Innovator in Protein-Binding Agents
Introduction
Xiaowei Wang is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of novel agents that target specific proteins. His work is aimed at addressing diseases associated with protein expression and activity.
Latest Patents
Xiaowei Wang holds a patent for Frizzled5 protein-binding agents. This patent focuses on innovative FZD5-binding agents and outlines methods and uses for treating diseases or disorders linked to aberrant expression or activity of Frizzled proteins. This advancement has the potential to impact therapeutic strategies significantly.
Career Highlights
Wang is associated with Modmab Therapeutics Corporation, where he applies his expertise in protein interactions to develop new therapeutic solutions. His work at Modmab Therapeutics highlights his commitment to advancing medical science through innovative research.
Collaborations
Xiaowei Wang collaborates with esteemed colleagues, including Guohua Pan and Jason Moffat. These partnerships enhance the research environment and foster the development of groundbreaking therapeutic agents.
Conclusion
Xiaowei Wang's contributions to the field of biotechnology, particularly through his patent on Frizzled5 protein-binding agents, exemplify his innovative spirit and dedication to improving health outcomes. His work continues to pave the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile